Atlas Trials

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

Clinical trial NCT05824728 · RECRUITING

Trial details

NCT number
NCT05824728
Sponsor
Johns Hopkins University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson Disease Psychosis
Start date
2023-09-28
Primary completion
2026-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.